Coronavirus disease 2019 (COVID-19) is a pandemic that started in China in December 2019 and carries a high risk of morbidity and mortality. To-date (4-22-2020) it affected over 2.6 million people and resulted in nearly 200,000 death worldwide mainly due to severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). Among the major underlying pathophysiologic mechanisms in COVID 19 is hypercoagulability, leading to increased risk for deep vein thrombosis and pulmonary embolism that contribute to increased morbidity and mortality. In this report, we present the case of a 55-year-old man who presented with COVID-19 pneumonia, and was found to have a thrombus in transit by routine point of care ultrasound (POCUS). While computer tomography (CT) angiography is the test of choice, the utilization of point of care ultrasound (POCUS) has gained traction as an adjunctive means of surveillance for the development of VTE in patients with COVID-19. In this report, we discuss the clinical utility of POCUS in diagnosing thrombus in transit in COVID 19 populations.
【저자키워드】 SARS-CoV-2, Pneumonia, COVID 19, POCUS, Pulmonary embolism, Deep vein thrombosis, 【초록키워드】 COVID-19, Coronavirus disease 2019, coronavirus, pandemic, thrombosis, computer tomography, point of care, China, Surveillance, death, morbidity and mortality, Thrombus, mechanism, hypercoagulability, VTE, high risk, acute respiratory syndrome, increased risk, clinical utility, diagnosing, while, populations, affected, contribute, pathophysiologic, patients with COVID-19, with COVID-19, 【제목키워드】 pulmonary, Embolism, with COVID-19,